\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ examination\\ and\\ laboratory\\ data\\ were\\ noncontributory\ \(0\)\
\-\ complete\\ resection\\ is\\ often\\ curative\\,\\ but\\ will\\ recur\\ if\\ incomplete\\.\\ \\ chemotherapy\\ is\\ used\\ in\\ cases\\ of\\ recurrence\\.\ \(0\)\
\-\ diffuse\\ encephalomalacic\\ changes\\ are\\ seen\\ in\\ the\\ right\\ cerebellum\\ secondary\\ to\\ a\\ right\\ suboccipital\\ craniectomy\\.\\ \\ a\\ heterogeneous\\ cystic\\ and\\ solid\\ lesion\\ is\\ seen\\ at\\ the\\ right\\ cerebellopontine\\ angle\\ with\\ heterogeneous\\ contrast\\ enhancement\\ of\\ a\\ mural\\ nodule\\.\ \(0\)\
\-\ juvenile\\ pilocytic\\ astrocytoma\ \(4\)\
\-\ pilocytic\\ astrocytoma\ \(31\)\
\-\ medulloblastoma\\ \ \(8\)\
\-\ hemangioblastoma\ \(37\)\
\-\ ependymoma\ \(74\)\
\-\ this\\ patient\\ originally\\ presented\\ at\\ the\\ age\\ of\\ 3\\ with\\ right\\ facial\\ palsy\\,\\ worsening\\ over\\ a\\ six\\ month\\ period\\,\\ now\\ undergoing\\ routine\\ surveillance\\ post\\-resection\\ and\\ chemotherapy\\ for\\ a\\ cns\\ tumor\\.\ \(0\)\
\-\ tumors\\ of\\ the\\ posterior\\ fossa\\ are\\ the\\ most\\ common\\ brain\\ tumor\\ in\\ children\\.\\ \\ they\\ often\\ present\\ with\\ symptoms\\ of\\ hydrocephalus\\ \\(e\\.g\\.\\ headache\\,\\ vomiting\\ and\\ vertigo\\)\\,\\ cranial\\ nerve\\ or\\ cerebellar\\ symptoms\\ \\(e\\.g\\.\\ ataxia\\)\\.\\ \\ obstruction\\ of\\ the\\ fourth\\ ventricle\\ leading\\ to\\ hydrocephalus\\ is\\ not\\ uncommon\\.\\ \\ cerebellar\\ signs\\ may\\ be\\ unilateral\\ or\\ axial\\ depending\\ on\\ involvement\\ of\\ the\\ vermis\\ or\\ a\\ single\\ hemisphere\\.\\ \\ astrocytomas\\ and\\ medulloblastomas\\ are\\ the\\ most\\ common\\ posterior\\ fossa\\ tumors\\ in\\ children\\ and\\ present\\ with\\ similar\\ frequency\\.\\ \\ ependymomas\\ and\\ hemangioblastomas\\ are\\ also\\ commonly\\ seen\\.\ \(0\)\
\-\ astrocytomas\\ are\\ common\\ in\\ children\\ but\\ are\\ not\\ uncommon\\ in\\ adults\\.\\ \\ the\\ incidence\\ is\\ similar\\ between\\ male\\ and\\ female\\,\\ with\\ perhaps\\ a\\ slight\\ female\\ predominance\\.\\ \\ pilocytic\\ astrocytomas\\ are\\,\\ by\\ definition\\,\\ low\\-grade\\ \\(who\\ grade\\ i\\)\\ tumors\\.\\ \\ they\\ are\\ well\\ circumscribed\\ lesions\\ and\\ may\\ be\\ cystic\\,\\ solid\\ or\\ both\\.\\ \\ the\\ cystic\\ form\\ is\\ seen\\ in\\ greater\\ than\\ 75\\%\\ of\\ lesions\\ and\\ has\\ a\\ classic\\ appearance\\ of\\ a\\ mural\\ nodule\\ in\\ a\\ cyst\\.\\ \\ with\\ mri\\,\\ the\\ mural\\ tumor\\ appears\\ iso\\-\\ or\\ hypointense\\ on\\ t1\\-weighted\\ images\\ and\\ iso\\-\\ to\\ hyperintense\\ on\\ t2\\-weight\\ images\\.\\ \\ the\\ cyst\\ wall\\ does\\ not\\ consist\\ of\\ tumor\\ cells\\ and\\ thus\\ will\\ not\\ enhance\\ on\\ ct\\ or\\ mri\\.\\ \\ complete\\ resection\\ is\\ often\\ curative\\,\\ however\\ solid\\ tumors\\ may\\ not\\ be\\ as\\ amenable\\ to\\ resection\\ if\\ the\\ fourth\\ ventricle\\ is\\ involved\\.\ \(0\)\
\-\ medulloblastoma\\,\\ a\\ primitive\\ neuroectodermal\\ tumor\\,\\ is\\ rare\\ in\\ adulthood\\,\\ most\\ commonly\\ occurring\\ between\\ ages\\ 5\\ and\\ 15\\ with\\ a\\ 2\\:1\\ male\\ predominance\\.\\ \\ these\\ highly\\ malignant\\ tumors\\ usually\\ arise\\ in\\ the\\ midline\\ in\\ the\\ posterior\\ fossa\\ \\(85\\%\\)\\.\\ \\ medulloblastoma\\ appears\\ hypointense\\ on\\ t1\\,\\ hyperintense\\ on\\ t2\\ and\\ enhances\\ with\\ contrast\\.\\ \\ it\\ may\\ appear\\ well\\-circumscribed\\ but\\ is\\ often\\ found\\ to\\ be\\ invasive\\ at\\ the\\ margins\\ on\\ histology\\,\\ often\\ invades\\ the\\ fourth\\ ventricle\\ and\\ will\\ seed\\ the\\ subarachnoid\\ space\\ \\â\\€\\“\\ necessitating\\ surveillance\\ of\\ the\\ spinal\\ cord\\.\\ \\ death\\ usually\\ comes\\ within\\ months\\ if\\ not\\ treated\\.\\ \\ resection\\,\\ chemotherapy\\ and\\ radiation\\ can\\ extend\\ life\\,\\ with\\ 60\\-75\\%\\ survival\\ at\\ five\\ years\\.\ \(0\)\
\-\ hemangioblastomas\\ are\\ benign\\,\\ low\\-grade\\ \\(who\\ grade\\ i\\)\\ tumors\\ that\\ are\\ associated\\ with\\ von\\ hippel\\-lindau\\ disease\\,\\ but\\ also\\ occur\\ in\\ isolation\\.\\ \\ they\\ have\\ a\\ very\\ similar\\ appearance\\ on\\ mri\\ to\\ astrocytomas\\,\\ consisting\\ of\\ a\\ cyst\\ with\\ mural\\ module\\,\\ but\\ may\\ also\\ be\\ solid\\ or\\ multiple\\ with\\ von\\ hippel\\-lindau\\.\\ \\ the\\ mural\\ nodule\\ enhances\\ and\\ has\\ classic\\ flow\\ and\\ enhancement\\ features\\ on\\ angiography\\.\\ \\ as\\ with\\ pilocytic\\ astrocytoma\\ complete\\ resection\\ is\\ often\\ curative\\,\\ however\\ recurrence\\ is\\ not\\ uncommon\\.\ \(0\)\
\-\ ependymomas\\ most\\ commonly\\ arise\\ in\\ the\\ floor\\ of\\ the\\ fourth\\ ventricle\\.\\ \\ this\\ is\\ a\\ malignant\\ tumor\\ that\\ can\\ spread\\ throughout\\ the\\ ventricular\\ system\\.\\ \\ this\\ mass\\ can\\ be\\ differentiated\\ from\\ the\\ others\\ discussed\\ here\\ as\\ it\\ often\\ has\\ calcifications\\ on\\ ct\\.\\ \\ complete\\ resection\\ is\\ rarely\\ achievable\\,\\ but\\ these\\ are\\ usually\\ radiosensitive\\.\\ \\ on\\ mri\\,\\ ependymomas\\ may\\ appear\\ as\\ multiple\\ small\\ cysts\\ that\\ enhance\\ with\\ contrast\\.\ \(0\)\
\-\ mri\\ is\\ the\\ leading\\ diagnostic\\ and\\ surveillance\\ modality\\ for\\ posterior\\ fossa\\ tumors\\.\\ \\ it\\ provides\\ greater\\ detail\\ of\\ the\\ lesion\\ and\\ has\\ been\\ shown\\ to\\ be\\ more\\ sensitive\\ and\\ specific\\ than\\ ct\\.\\ \\ although\\ pediatric\\ patients\\ are\\ more\\ frequently\\ sedated\\ for\\ mri\\ studies\\,\\ there\\ is\\ no\\ radiation\\ and\\ no\\ iodinated\\ contrast\\ as\\ with\\ ct\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mural\\:\\ 0\\.03581940136513306\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.03490513499894158\ \(0\)\
\-\ tumors\\:\\ 0\\.033089859357427844\ \(0\)\
\-\ ependymomas\\:\\ 0\\.0287758468231478\ \(0\)\
\-\ often\\:\\ 0\\.028107974727006723\ \(0\)\
\-\ pilocytic\\:\\ 0\\.026497969428160167\ \(0\)\
\-\ curative\\:\\ 0\\.025292235510787256\ \(0\)\
\-\ fourth\\:\\ 0\\.024349850938687943\ \(0\)\
\-\ resection\\:\\ 0\\.02354859194863227\ \(0\)\
\-\ surveillance\\:\\ 0\\.02350078437039772\ \(0\)\
\-\ medulloblastoma\\:\\ 0\\.021938309965786922\ \(0\)\
\-\ hemangioblastomas\\:\\ 0\\.021882839654923734\ \(0\)\
\-\ are\\:\\ 0\\.0205868725631152\ \(0\)\
\-\ fossa\\:\\ 0\\.02051722904684023\ \(0\)\
\-\ solid\\:\\ 0\\.020078625346134783\ \(0\)\
\-\ iso\\-\\:\\ 0\\.018903160975458404\ \(0\)\
\-\ ventricle\\:\\ 0\\.01886533324052093\ \(0\)\
\-\ uncommon\\:\\ 0\\.01847182372195963\ \(0\)\
\-\ complete\\:\\ 0\\.017716500347487802\ \(0\)\
\-\ tumor\\:\\ 0\\.017604409145309082\ \(0\)\
\-\ mri\\:\\ 0\\.01734853480042374\ \(0\)\
\-\ hippel\\-lindau\\:\\ 0\\.01714222724716497\ \(0\)\
\-\ may\\:\\ 0\\.01656254817877576\ \(0\)\
\-\ children\\:\\ 0\\.016310255277893544\ \(0\)\
\-\ but\\:\\ 0\\.0161045947072183\ \(0\)\
\-\ von\\:\\ 0\\.015851343798177767\ \(0\)\
\-\ predominance\\:\\ 0\\.01575782775012304\ \(0\)\
\-\ nodule\\:\\ 0\\.015562063030524327\ \(0\)\
\-\ low\\-grade\\:\\ 0\\.015410896864537227\ \(0\)\
\-\ similar\\:\\ 0\\.01480863012786843\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.014661341083976272\ \(0\)\
\-\ commonly\\:\\ 0\\.014246825228817267\ \(0\)\
\-\ they\\:\\ 0\\.013603591133228156\ \(0\)\
\-\ be\\:\\ 0\\.013585120859215764\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.013532897430666562\ \(0\)\
\-\ e\\.g\\:\\ 0\\.013328597887534925\ \(0\)\
\-\ is\\:\\ 0\\.013249856338962607\ \(0\)\
\-\ encephalomalacic\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ post\\-resection\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ module\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ achievable\\:\\ 0\\.012983090462395432\ \(0\)\
\-\ not\\:\\ 0\\.012730089399401396\ \(0\)\
\-\ arise\\:\\ 0\\.012461122077454864\ \(0\)\
\-\ enhance\\:\\ 0\\.012174925469343971\ \(0\)\
\-\ leading\\:\\ 0\\.012041621812236104\ \(0\)\
\-\ t2\\-weight\\:\\ 0\\.011962255144928649\ \(0\)\
\-\ 60\\-75\\:\\ 0\\.011962255144928649\ \(0\)\
\-\ hypointense\\:\\ 0\\.011939159025533849\ \(0\)\
\-\ enhances\\:\\ 0\\.011889233964226711\ \(0\)\
\-\ will\\:\\ 0\\.011812139992838625\ \(0\)\
\-\ on\\:\\ 0\\.01172724762300399\ \(0\)\
\-\ most\\:\\ 0\\.011622003780430492\ \(0\)\
\-\ posterior\\:\\ 0\\.011603172599130771\ \(0\)\
\-\ usually\\:\\ 0\\.011465073286598347\ \(0\)\
\-\ medulloblastomas\\:\\ 0\\.011365104764798805\ \(0\)\
\-\ radiosensitive\\:\\ 0\\.011365104764798805\ \(0\)\
\-\ contrast\\:\\ 0\\.011268192558514906\ \(0\)\
\-\ recurrence\\:\\ 0\\.010980624709084284\ \(0\)\
\-\ cystic\\:\\ 0\\.010889393404646943\ \(0\)\
\-\ cerebellar\\:\\ 0\\.010856022707049853\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.01082136927088023\ \(0\)\
\-\ seed\\:\\ 0\\.010612784258516049\ \(0\)\
\-\ hyperintense\\:\\ 0\\.010449662046842917\ \(0\)\
\-\ i\\:\\ 0\\.01040446154706483\ \(0\)\
\-\ \\,\\:\\ 0\\.010365922980043405\ \(0\)\
\-\ isolation\\:\\ 0\\.010344269447332022\ \(0\)\
\-\ or\\:\\ 0\\.010324976793440284\ \(0\)\
\-\ appear\\:\\ 0\\.010301615405367545\ \(0\)\
\-\ if\\:\\ 0\\.010244816349546253\ \(0\)\
\-\ cyst\\:\\ 0\\.010145969673163929\ \(0\)\
\-\ invades\\:\\ 0\\.010117243409294823\ \(0\)\
\-\ seen\\:\\ 0\\.009947732636628513\ \(0\)\
\-\ amenable\\:\\ 0\\.009920584509995084\ \(0\)\
\-\ 2\\:1\\:\\ 0\\.009920584509995084\ \(0\)\
\-\ common\\:\\ 0\\.009880414780366997\ \(0\)\
\-\ sedated\\:\\ 0\\.009747119067202176\ \(0\)\
\-\ iodinated\\:\\ 0\\.009747119067202176\ \(0\)\
\-\ classic\\:\\ 0\\.009644344267475912\ \(0\)\
\-\ craniectomy\\:\\ 0\\.009591948941049267\ \(0\)\
\-\ necessitating\\:\\ 0\\.009591948941049267\ \(0\)\
\-\ grade\\:\\ 0\\.009587148138294463\ \(0\)\
\-\ as\\:\\ 0\\.00951824378419829\ \(0\)\
\-\ greater\\:\\ 0\\.00945424553069367\ \(0\)\
\-\ has\\:\\ 0\\.00945331352279398\ \(0\)\
\-\ appears\\:\\ 0\\.009368862506030187\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.009255361286583226\ \(0\)\
\-\ suboccipital\\:\\ 0\\.009205550907960177\ \(0\)\
\-\ malignant\\:\\ 0\\.009097704495962596\ \(0\)\
\-\ neuroectodermal\\:\\ 0\\.0088997491925283\ \(0\)\
\-\ \\%\\:\\ 0\\.008807014874871904\ \(0\)\
\-\ a\\:\\ 0\\.008761409465801206\ \(0\)\
\-\ detail\\:\\ 0\\.008726283749735395\ \(0\)\
\-\ can\\:\\ 0\\.008563574458626228\ \(0\)\
\-\ recur\\:\\ 0\\.008499257711698195\ \(0\)\
\-\ it\\:\\ 0\\.008486811713695213\ \(0\)\
\-\ adulthood\\:\\ 0\\.008430745170262419\ \(0\)\
\-\ radiation\\:\\ 0\\.00825994477043398\ \(0\)\
\-\ perhaps\\:\\ 0\\.008242478054636668\ \(0\)\
\-\ comes\\:\\ 0\\.008242478054636668\ \(0\)\
\-\ primitive\\:\\ 0\\.008184715590493396\ \(0\)\
\-\ consist\\:\\ 0\\.008129133369605551\ \(0\)\
\-\ in\\:\\ 0\\.008067988205925353\ \(0\)\
\-\ vertigo\\:\\ 0\\.00802389189098678\ \(0\)\
\-\ between\\:\\ 0\\.007977895541161248\ \(0\)\
\-\ cerebellopontine\\:\\ 0\\.007973963243452639\ \(0\)\
\-\ vermis\\:\\ 0\\.007973963243452639\ \(0\)\
\-\ definition\\:\\ 0\\.007973963243452639\ \(0\)\
\-\ consisting\\:\\ 0\\.007925671899088884\ \(0\)\
\-\ provides\\:\\ 0\\.007789628717747182\ \(0\)\
\-\ histology\\:\\ 0\\.007478422394231413\ \(0\)\
\-\ also\\:\\ 0\\.0074430909882333635\ \(0\)\
\-\ others\\:\\ 0\\.007409909852795636\ \(0\)\
\-\ appearance\\:\\ 0\\.0071985466177750855\ \(0\)\
\-\ ages\\:\\ 0\\.0071358269667369315\ \(0\)\
\-\ originally\\:\\ 0\\.007108298052138768\ \(0\)\
\-\ floor\\:\\ 0\\.007081274283849819\ \(0\)\
\-\ ct\\:\\ 0\\.007041553186403787\ \(0\)\
\-\ occurring\\:\\ 0\\.007028670333036742\ \(0\)\
\-\ 85\\:\\ 0\\.007028670333036742\ \(0\)\
\-\ however\\:\\ 0\\.007008447880992844\ \(0\)\
\-\ palsy\\:\\ 0\\.006977880677556375\ \(0\)\
\-\ hemangioblastoma\\:\\ 0\\.006953127925985858\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.006904836581622101\ \(0\)\
\-\ modality\\:\\ 0\\.006904836581622101\ \(0\)\
\-\ discussed\\:\\ 0\\.00688127201410157\ \(0\)\
\-\ juvenile\\:\\ 0\\.006858078557594736\ \(0\)\
\-\ sensitive\\:\\ 0\\.006835244704080796\ \(0\)\
\-\ at\\:\\ 0\\.006820401489435246\ \(0\)\
\-\ data\\:\\ 0\\.006812759472665791\ \(0\)\
\-\ incomplete\\:\\ 0\\.006790612377872655\ \(0\)\
\-\ death\\:\\ 0\\.006790612377872655\ \(0\)\
\-\ survival\\:\\ 0\\.006747292959306684\ \(0\)\
\-\ enhancement\\:\\ 0\\.006746653213911741\ \(0\)\
\-\ lesions\\:\\ 0\\.0067380280010131\ \(0\)\
\-\ ataxia\\:\\ 0\\.006726101887948658\ \(0\)\
\-\ differentiated\\:\\ 0\\.006726101887948658\ \(0\)\
\-\ well\\-circumscribed\\:\\ 0\\.0066642989437674625\ \(0\)\
\-\ frequency\\:\\ 0\\.006644261164598421\ \(0\)\
\-\ than\\:\\ 0\\.006595136538787258\ \(0\)\
\-\ here\\:\\ 0\\.00656672989289677\ \(0\)\
\-\ who\\:\\ 0\\.0065624989959991225\ \(0\)\
\-\ these\\:\\ 0\\.00655035255363134\ \(0\)\
\-\ depending\\:\\ 0\\.0065479684410890675\ \(0\)\
\-\ that\\:\\ 0\\.006521269787446936\ \(0\)\
\-\ cns\\:\\ 0\\.006440157831334583\ \(0\)\
\-\ 75\\:\\ 0\\.006440157831334583\ \(0\)\
\-\ adults\\:\\ 0\\.00642293244140352\ \(0\)\
\-\ hemisphere\\:\\ 0\\.006405906193390154\ \(0\)\
\-\ invasive\\:\\ 0\\.006323608021969746\ \(0\)\
\-\ angiography\\:\\ 0\\.006323608021969746\ \(0\)\
\-\ extend\\:\\ 0\\.006307686201492256\ \(0\)\
\-\ more\\:\\ 0\\.006295070130521845\ \(0\)\
\-\ five\\:\\ 0\\.006276349826753988\ \(0\)\
\-\ symptoms\\:\\ 0\\.006272923348742678\ \(0\)\
\-\ cerebellum\\:\\ 0\\.006260928177464892\ \(0\)\
\-\ thus\\:\\ 0\\.006260928177464892\ \(0\)\
\-\ unilateral\\:\\ 0\\.006245666340888241\ \(0\)\
\-\ six\\:\\ 0\\.006186153029639527\ \(0\)\
\-\ undergoing\\:\\ 0\\.006171643020150555\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.006114991649270149\ \(0\)\
\-\ spread\\:\\ 0\\.006087462734671986\ \(0\)\
\-\ highly\\:\\ 0\\.0060604389663830366\ \(0\)\
\-\ pediatric\\:\\ 0\\.0060604389663830366\ \(0\)\
\-\ noncontributory\\:\\ 0\\.006033902139427692\ \(0\)\
\-\ rarely\\:\\ 0\\.006033902139427692\ \(0\)\
\-\ slight\\:\\ 0\\.00592007051306297\ \(0\)\
\-\ angle\\:\\ 0\\.00590794901212554\ \(0\)\
\-\ period\\:\\ 0\\.005884001264155318\ \(0\)\
\-\ form\\:\\ 0\\.005884001264155318\ \(0\)\
\-\ and\\:\\ 0\\.005832397829320775\ \(0\)\
\-\ incidence\\:\\ 0\\.0057697770604058715\ \(0\)\
\-\ margins\\:\\ 0\\.005715823992394413\ \(0\)\
\-\ present\\:\\ 0\\.005684856418060915\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.005663777797335048\ \(0\)\
\-\ ependymoma\\:\\ 0\\.005633410658597587\ \(0\)\
\-\ ventricular\\:\\ 0\\.00562342584713164\ \(0\)\
\-\ circumscribed\\:\\ 0\\.005593871262373451\ \(0\)\
\-\ life\\:\\ 0\\.005490312354542142\ \(0\)\
\-\ facial\\:\\ 0\\.005472241525982768\ \(0\)\
\-\ cranial\\:\\ 0\\.005472241525982768\ \(0\)\
\-\ frequently\\:\\ 0\\.005454389743166355\ \(0\)\
\-\ \\(\\:\\ 0\\.005319305789719149\ \(0\)\
\-\ right\\:\\ 0\\.005311527005068728\ \(0\)\
\-\ features\\:\\ 0\\.005310798631995696\ \(0\)\
\-\ multiple\\:\\ 0\\.005301343161941882\ \(0\)\
\-\ the\\:\\ 0\\.005293787043143256\ \(0\)\
\-\ involved\\:\\ 0\\.005278954060547734\ \(0\)\
\-\ \\)\\:\\ 0\\.005254327629700332\ \(0\)\
\-\ specific\\:\\ 0\\.005202230773532415\ \(0\)\
\-\ female\\:\\ 0\\.00517455160956652\ \(0\)\
\-\ lesion\\:\\ 0\\.005126819516938011\ \(0\)\
\-\ single\\:\\ 0\\.005101119720899015\ \(0\)\
\-\ routine\\:\\ 0\\.005046313246170836\ \(0\)\
\-\ cells\\:\\ 0\\.005046313246170836\ \(0\)\
\-\ shown\\:\\ 0\\.005046313246170836\ \(0\)\
\-\ 15\\:\\ 0\\.005019656336533696\ \(0\)\
\-\ diagnostic\\:\\ 0\\.004986999698103177\ \(0\)\
\-\ worsening\\:\\ 0\\.004955051502799407\ \(0\)\
\-\ system\\:\\ 0\\.004955051502799407\ \(0\)\
\-\ cysts\\:\\ 0\\.00492998274349244\ \(0\)\
\-\ rare\\:\\ 0\\.004887113694658757\ \(0\)\
\-\ midline\\:\\ 0\\.004869116476198116\ \(0\)\
\-\ images\\:\\ 0\\.004828465072015771\ \(0\)\
\-\ used\\:\\ 0\\.0048279589940323445\ \(0\)\
\-\ vomiting\\:\\ 0\\.004804946743806893\ \(0\)\
\-\ cord\\:\\ 0\\.004782288542275996\ \(0\)\
\-\ occur\\:\\ 0\\.004721718157262944\ \(0\)\
\-\ throughout\\:\\ 0\\.004710968079970437\ \(0\)\
\-\ studies\\:\\ 0\\.004700295902472989\ \(0\)\
\-\ calcifications\\:\\ 0\\.004679180787382551\ \(0\)\
\-\ laboratory\\:\\ 0\\.004637837608032497\ \(0\)\
\-\ involvement\\:\\ 0\\.004612575341130805\ \(0\)\
\-\ very\\:\\ 0\\.0045681673320429\ \(0\)\
\-\ male\\:\\ 0\\.0045514154282399796\ \(0\)\
\-\ nerve\\:\\ 0\\.004534530377742719\ \(0\)\
\-\ spinal\\:\\ 0\\.004506297806155502\ \(0\)\
\-\ obstruction\\:\\ 0\\.004437997126052188\ \(0\)\
\-\ signs\\:\\ 0\\.0044291250868719505\ \(0\)\
\-\ to\\:\\ 0\\.004402764004566869\ \(0\)\
\-\ benign\\:\\ 0\\.004343225871919295\ \(0\)\
\-\ headache\\:\\ 0\\.0043225116900821765\ \(0\)\
\-\ now\\:\\ 0\\.004302084815466344\ \(0\)\
\-\ does\\:\\ 0\\.0042939927398880804\ \(0\)\
\-\ although\\:\\ 0\\.0042502640361952925\ \(0\)\
\-\ this\\:\\ 0\\.004246556170754638\ \(0\)\
\-\ cases\\:\\ 0\\.004192652229721845\ \(0\)\
\-\ space\\:\\ 0\\.004162823279936134\ \(0\)\
\-\ flow\\:\\ 0\\.0041591367847695375\ \(0\)\
\-\ t1\\:\\ 0\\.003988947770580624\ \(0\)\
\-\ found\\:\\ 0\\.003966164380636395\ \(0\)\
\-\ examination\\:\\ 0\\.003912257784204072\ \(0\)\
\-\ age\\:\\ 0\\.003830501215823721\ \(0\)\
\-\ diffuse\\:\\ 0\\.0038100256559282985\ \(0\)\
\-\ brain\\:\\ 0\\.0037869683701071606\ \(0\)\
\-\ month\\:\\ 0\\.0037755736977917666\ \(0\)\
\-\ treated\\:\\ 0\\.003767085178326744\ \(0\)\
\-\ years\\:\\ 0\\.00369549799266345\ \(0\)\
\-\ 5\\:\\ 0\\.0036821213879884586\ \(0\)\
\-\ wall\\:\\ 0\\.0036453006189083154\ \(0\)\
\-\ changes\\:\\ 0\\.0036068453258248315\ \(0\)\
\-\ axial\\:\\ 0\\.003591740023664023\ \(0\)\
\-\ t2\\:\\ 0\\.0035619864046396938\ \(0\)\
\-\ secondary\\:\\ 0\\.0035184535589231334\ \(0\)\
\-\ months\\:\\ 0\\.0034373214943889062\ \(0\)\
\-\ presented\\:\\ 0\\.0034305708910492036\ \(0\)\
\-\ been\\:\\ 0\\.003423851089048588\ \(0\)\
\-\ patients\\:\\ 0\\.0032571054482562973\ \(0\)\
\-\ for\\:\\ 0\\.0032213909365657514\ \(0\)\
\-\ both\\:\\ 0\\.0032138438743536395\ \(0\)\
\-\ over\\:\\ 0\\.003204186436141329\ \(0\)\
\-\ physical\\:\\ 0\\.003087636626776492\ \(0\)\
\-\ associated\\:\\ 0\\.0029697534048714314\ \(0\)\
\-\ 3\\:\\ 0\\.0029469448110552867\ \(0\)\
\-\ small\\:\\ 0\\.0028992272229471554\ \(0\)\
\-\ were\\:\\ 0\\.0028575645606626235\ \(0\)\
\-\ well\\:\\ 0\\.002846952802604788\ \(0\)\
\-\ have\\:\\ 0\\.002725240174322668\ \(0\)\
\-\ with\\:\\ 0\\.002584775613178713\ \(0\)\
\-\ no\\:\\ 0\\.0025344452156223917\ \(0\)\
\-\ of\\:\\ 0\\.0024021402226389365\ \(0\)\
\-\ within\\:\\ 0\\.002400782633852845\ \(0\)\
\-\ by\\:\\ 0\\.0020955388854858245\ \(0\)\
\-\ disease\\:\\ 0\\.0020570508707153227\ \(0\)\
\-\ \\.\\:\\ 0\\.001986719251397877\ \(0\)\
\-\ there\\:\\ 0\\.001872924236325462\ \(0\)\
\-\ from\\:\\ 0\\.001865148325705762\ \(0\)\
\-\ mass\\:\\ 0\\.0017503107613366193\ \(0\)\
\-\ patient\\:\\ 0\\.001261549235517508\ \(0\)\
